New offering aims to help customers comply with emerging cybersecurity regulations.

  • Nordic Semiconductor unveils a new lifetime flat-rate FOTA solution.
  • The solution is designed to support compliance with the Cyber Resilience Act.
  • Customers will benefit from enhanced cybersecurity measures.

Nordic Semiconductor has launched a lifetime flat-rate firmware over-the-air (FOTA) solution aimed at aiding customers in meeting the requirements of the Cyber Resilience Act. This new offering allows companies to efficiently manage software updates, ensuring they maintain compliance with evolving cybersecurity regulations. The FOTA solution is strategically positioned to enhance security measures across various applications.

The Cyber Resilience Act emphasizes the importance of strong cybersecurity practices within the tech industry, and Nordic Semiconductor's flat-rate solution addresses this critical need. By facilitating consistent and reliable software updates, the FOTA solution aims to bolster the security of connected devices. This development underscores the commitment of Nordic Semiconductor to support their customers in navigating the complexities of regulatory requirements.

This new approach not only simplifies the update process but also aims to protect devices from potential vulnerabilities. As companies face increasing scrutiny regarding their cybersecurity frameworks, solutions like Nordic’s FOTA can play a vital role in ensuring ongoing compliance and protection against cyber threats.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

HelpMeSee Unveils Next-Generation MSICS Training System at SAFO

New training system aims to improve global solutions for blindness. HelpMeSee launches…

Volta Labs and Watchmaker Genomics Partner for DNA Library Prep Kit

New Callisto Complete Kit simplifies DNA library preparation for researchers. Volta Labs…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…